Platelet Rich Plasma Market USD 345 Million by 2020, Published by iHealthcareAnalyst, Inc.

Maryland Heights, MO, October 21, 2016 --(PR.com)-- The global platelet rich plasma market is estimated to reach USD 345 Million in 2020, growing at a CAGR of 11.5% from 2016 to 2020, according to a market research report Platelet Rich Plasma Market 2013-2020, published by iHealthcareAnalyst, Inc.

Visit the Platelet Rich Plasma Market 2013-2020 report at https://www.ihealthcareanalyst.com/report/platelet-rich-plasma-market/

The global platelet rich plasma market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global platelet rich plasma market segmentation is based on product types (leukocyte-platelet rich fibrin, leukocyte-platelet rich plasma, pure-platelet rich plasma), source types (allogenic, autologus, homologus), and applications (cosmetic surgery, general surgery, neurosurgery, orthopedic surgery, and surgeries like oral and maxillofacial, cardiothoracic, periodontal, urological).

The global platelet rich plasma market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global platelet rich plasma market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Product Type
1.1. Leukocyte-Platelet Rich Fibrin (L-PRF)
1.2. Leukocyte-Platelet Rich Plasma (L-PRP)
1.3. Pure-Platelet Rich Plasma (P-PRP)

2. Source Type
2.1. Allogenic
2.2. Autologus
2.3. Homologus

3. Application
3.1. Cosmetic Surgery
3.2. General Surgery
3.3. Neurosurgery
3.4. Orthopedic Surgery
3.5. Other Surgeries (Oral and Maxillofacial, Cardiothoracic, Periodontal, Urological, etc.)

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Latin America (Brazil, Mexico, Rest of LA)
4.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.4. Asia Pacific (Japan, China, India, Rest of APAC)
4.5. Rest of the World

5. Company Profiles
5.1. AdiStem Ltd.
5.2. Arteriocyte Medical Systems, Inc.
5.3. Arthrex, Inc.
5.4. Biomet, Inc.
5.5. Cesca Therapeutics, Inc.
5.6. DePuy Synthes, Inc. (DePuy Mitek Sports Medicine)
5.7. Dr. PRP America LLC
5.8. EmCyte Corporation
5.9. Exactech, Inc.
5.10. Harvest Technologies Corp.
5.11. Nuo Therapeutics, Inc. (Cytomedix, Inc.)
5.12. Regen Lab SA
5.13. Stryker Corporation

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: https://www.ihealthcareanalyst.com